Neoadjuvant pembrolizumab achieved a 71% pCR rate in desmoplastic melanoma, surpassing expectations for neoadjuvant anti–PD-1 ...
Neoadjuvant chemotherapy (NACT) combined with pembrolizumab or with human epidermal growth factor receptor 2 (HER2)–directed agents, namely trastuzumab and pertuzumab, represents the standard of care ...
Polymerase chain reaction (PCR) is a fundamental molecular biology tool that scientists use to amplify and analyze genetic material, such as DNA and RNA. PCR involves the enzymatic amplification of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results